Skip to Content
Merck
All Photos(1)

Documents

1.25138

Millipore

Fractogel® EMD TMAE (S)

RoboColumn Fractogel® TMAE (S), volume 0.6 mL, prepacked column

Synonym(s):

RoboColumn Fractogel® TMAE (S), 0.6 ml

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41115711

ligand

(Trimethylammoniumethyl)

Quality Level

material

polypropylene housing

product line

Fractogel®

form

prepacked column

parameter

≤8 bar pressure
~80 cm/hr max. flow rate

column I.D. × L

5 mm × 30 mm

volume

0.6 mL

matrix active group

Methacrylate

mean particle size

20-40 μm

capacity

~100 mg, BSA binding capacity

application(s)

gene therapy
recombinant protein
vaccine development

separation technique

anion exchange

Looking for similar products? Visit Product Comparison Guide

General description

5 x 30 mm

Features and Benefits

RoboColumn Fractogel® TMAE (S), 0.6 ml enables:

High protein loading conditions resulting in good selectivity and resolution with the tentacle technology
  • Excellent binding to large viruses at increased loading
  • Homogenous binding with high selectivity and purity
  • Reduce operating costs and resin replacement with enduring durability - allowing for multiple cycles of column regeneration and sanitization
  • Compatibility with 2.5 % (v/v) aqueous benzyl alcohol containing 150 mM NaCl storage solution

Legal Information

FRACTOGEL is a registered trademark of Merck KGaA, Darmstadt, Germany

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Articles

Explore strategies for separating empty and filled capsids in viral vector production. Learn about upstream strategies and how trends in AAV capsid design impact purification.

Explore strategies for separating empty and filled capsids in viral vector production. Learn about upstream strategies and how trends in AAV capsid design impact purification.

Explore strategies for separating empty and filled capsids in viral vector production. Learn about upstream strategies and how trends in AAV capsid design impact purification.

Explore strategies for separating empty and filled capsids in viral vector production. Learn about upstream strategies and how trends in AAV capsid design impact purification.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service